We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.65B
1-Year Est. Return
203.21%
This Fund
S&P 500
This Quarter
Est. Return
-18.26%
1 Year Est. Return
+203.21%
3 Year Est. Return
+364.25%
5 Year Est. Return
+595.91%
10 Year Est. Return
+10,683%
AUM
$859M
AUM Growth
-$274M
(-24%)
Cap. Flow
+$11.4M
Cap. Flow
% of AUM
1.32%
Top 10 Holdings %
Top 10 Hldgs %
49.67%
Holding
76
New
1
Increased
28
Reduced
18
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NeoGenomics
NEO
|
+$18.2M |
| 2 |
SI-BONE Inc
SIBN
|
+$15.4M |
| 3 |
CRNX
Crinetics Pharmaceuticals
CRNX
|
+$13.1M |
| 4 |
AtriCure
ATRC
|
+$5.44M |
| 5 |
Axogen
AXGN
|
+$5.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$28.4M |
| 2 |
XENT
Intersect ENT, Inc
XENT
|
+$19.6M |
| 3 |
Sutro Biopharma
STRO
|
+$13.7M |
| 4 |
Krystal Biotech
KRYS
|
+$7.61M |
| 5 |
BCYC
Bicycle Therapeutics
BCYC
|
+$3.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 91.21% |
| 2 | Communication Services | 8.2% |
| 3 | Miscellaneous | 0.32% |
| 4 | Energy | 0.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MODN
1
DELISTED
MODEL N, INC.
MODN
| $70.4M | 8.2% |
2,753,758
+46,615
| +2% | +$1.16M |
|
|
2
AtriCure
ATRC
$2.86B
| $60.5M | 7.03% |
1,479,626
+114,814
| +8% | +$5.44M |
|
3
Prothena Corp
PRTA
$428M
| $52.6M | 6.12% |
1,938,183
+99,635
| +5% | +$2.91M |
|
|
4
Halozyme
HALO
$12.1B
| $41.4M | 4.82% |
941,245
-656,284
| -41% | -$28.4M |
|
|
SPNE
5
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $39.7M | 4.62% |
7,030,309
+24,521
| +0.4% | +$214K |
|
6
Omnicell
OMCL
$1.49B
| $39.5M | 4.59% |
347,029
+25,267
| +8% | +$2.9M |
|
|
7
Krystal Biotech
KRYS
$9.97B
| $39.1M | 4.55% |
595,612
-122,324
| -17% | -$7.61M |
|
|
CUTR
8
DELISTED
Cutera, Inc.
CUTR
| $28.9M | 3.37% |
771,814
-2,413
| -0.3% | -$127K |
|
9
Tandem Diabetes Care
TNDM
$1.13B
| $27.7M | 3.22% |
467,555
+32,250
| +7% | +$2.65M |
|
10
Ultragenyx Pharmaceutical
RARE
$1.29B
| $27M | 3.14% |
452,470
+14,958
| +3% | +$920K |
|
|
11
SI-BONE Inc
SIBN
$831M
| $26.5M | 3.08% |
2,006,304
+921,670
| +85% | +$15.4M |
|
|
12
Axogen
AXGN
$2.42B
| $24.8M | 2.88% |
3,025,119
+601,784
| +25% | +$5.14M |
|
|
CRNX
13
DELISTED
Crinetics Pharmaceuticals
CRNX
| $23.1M | 2.69% |
1,240,609
+657,842
| +113% | +$13.1M |
|
|
BLU
14
DELISTED
BELLUS Health Inc.
BLU
| $22.3M | 2.59% |
2,408,074
-83,269
| -3% | -$681K |
|
|
15
NeoGenomics
NEO
$2.43B
| $22.1M | 2.58% |
2,715,487
+1,909,529
| +237% | +$18.2M |
|
|
FNA
16
DELISTED
Paragon 28, Inc.
FNA
| $19.6M | 2.29% |
1,237,511
+118,908
| +11% | +$2M |
|
17
Alphatec Holdings
ATEC
$1.65B
| $19.1M | 2.23% |
2,924,964
+206,844
| +8% | +$1.91M |
|
|
AXNX
18
DELISTED
Axonics, Inc. Common Stock
AXNX
| $17.8M | 2.07% |
314,004
+34,494
| +12% | +$1.89M |
|
19
CareDx
CDNA
$2.72B
| $16.7M | 1.94% |
776,620
+54,547
| +8% | +$1.51M |
|
20
Keros Therapeutics
KROS
$221M
| $16.5M | 1.92% |
598,333
-59,812
| -9% | -$2.62M |
|
21
Health Catalyst
HCAT
$129M
| $16.4M | 1.91% |
1,135,165
+276,432
| +32% | +$4.71M |
|
|
KRTX
22
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $15.9M | 1.85% |
125,793
+8,924
| +8% | +$1.03M |
|
23
KORU Medical Systems
KRMD
$146M
| $15.4M | 1.8% |
6,102,934
+3,114
| +0.1% | +$7.56K |
|
24
Insmed
INSM
$26.2B
| $15M | 1.75% |
762,182
+24,388
| +3% | +$511K |
|
|
NGM
25
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $14.6M | 1.69% |
1,135,884
+319,231
| +39% | +$4.42M |
|
Similar funds
AAM
NPA
SOS
BCM
BFO
AAG
MCIL
TIM
First Light Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, First Light Asset Management held 76 positions worth $859M, down 24% from $1.13B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
First Light Asset Management's Q2 2022 filing shows 1 new, 28 increased, 18 reduced and 5 closed positions. Its largest new stake was iShares Russell 2000 Growth ETF: 13,242 shares worth $2.73M. The largest sale was Halozyme, an estimated $28.4M.
By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 93% a quarter earlier, followed by Communication Services and Miscellaneous.
- First Light Asset Management's largest Q2 2022 buy was iShares Russell 2000 Growth ETF: 13,242 shares worth $2.73M.
- First Light Asset Management added most to NeoGenomics in Q2 2022, an estimated $18.2M increase.
- First Light Asset Management's biggest Q2 2022 reduction was Halozyme, cutting an estimated $28.4M.
- First Light Asset Management fully exited Intersect ENT, Inc in Q2 2022, selling an estimated $19.6M.
- First Light Asset Management's ten largest holdings make up 50% of its $859M portfolio in Q2 2022.
- First Light Asset Management opened 1 new position and closed 5 in Q2 2022.
- First Light Asset Management's portfolio value fell 24% quarter-over-quarter to $859M.
Based on First Light Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.